Subsequent studies further illustrated the critical role of ZHX2 as a tumor suppressor in HCC with a variety of etiologies, including NASH-related HCC (34, 37) and HBV-related HCC (25, 32). This evidence concerns the gene ZHX2 and metabolic dysfunction-associated steatohepatitis.